Uroplakin II for Bladder Pathology
When it comes to diagnosis of Urothelial carcinoma of the bladder, the combination of Uroplakin II (UPII), GATA-3, and p40 has been found to provide a very high staining sensitivity, and more importantly, very high specificity. Alone, Uroplakin II has been proven to be even more sensitive than Uroplakin III, whilst retaining its high specificity. For that reason we are proud to be adding Uroplakin II to our selection of antibodies for Bladder Cancer diagnosis, offering you and patients a higher level of confidence in diagnosis.
Contact your local Menarini Cellular Pathology sales specialist today for more information on any of our Biocare antibodies including NEW Uroplakin II. If you would like to read more about our selection of antibodies for bladder pathology, then please click here to view our factsheet.